Physician profile
Scott C Carollo
NPI 1760459093
$18,952.47
in general payments reported to CMS, 2019-2025
30 companies · $214 in 2025
The $214 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,043 · 2020: $1,304 · 2021: $1,881 · 2022: $3,081 · 2023: $9,666 · 2024: $1,764 · 2025: $214.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,052 · Food and Beverage: $2,269 · Travel and Lodging: $838 · Consulting Fee: $485.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,051.75 |
| Food and Beverage | $2,269.23 |
| Travel and Lodging | $837.90 |
| Consulting Fee | $485.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $10,731.40 | 2019-2025 | Repatha, Repatha |
| Janssen Global Services, LLC | $1,575.00 | 2022 | |
| Medtronic, INC. | $1,102.15 | 2021-2025 | Onyx Frontier, Linq II |
| Astrazeneca Pharmaceuticals LP | $1,027.95 | 2019-2021 | |
| Boston Scientific Corporation | $680.21 | 2019-2024 | |
| Novartis Pharmaceuticals Corporation | $409.01 | 2019-2025 | |
| Abbott Laboratories | $406.40 | 2020-2023 | Amplatzer Amulet, Aveir |
| Shockwave Medical, INC | $400.64 | 2020-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Sanofi-Aventis U.S. LLC | $341.63 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $323.28 | 2019-2023 | Camzyos, Eliquis |
| Saranas, INC. | $321.10 | 2022 | |
| Edwards Lifesciences Corporation | $196.41 | 2024 | |
| Actelion Pharmaceuticals US, INC. | $179.41 | 2021-2023 | Opsumit, Uptravi |
| Medtronic Vascular, INC. | $141.48 | 2020 | |
| Zoll Circulation INC | $135.04 | 2020-2021 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $126.89 | 2019-2025 | |
| Teleflex LLC | $124.92 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $119.15 | 2019-2023 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $100.66 | 2023 | Jardiance |
| Janssen Pharmaceuticals, INC | $82.09 | 2019-2022 | |
| Chiesi USA, INC. | $74.42 | 2020-2021 | |
| Cardiovascular Systems INC. | $65.04 | 2021 | |
| Philips North America LLC | $61.57 | 2019 | |
| Abiomed | $55.95 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $44.46 | 2021-2025 | Verquvo |
| Regeneron Healthcare Solutions, INC. | $37.05 | 2019-2025 | Evkeeza |
| Scpharmaceuticals INC. | $30.08 | 2023-2024 | |
| Kestra Medical Technology Services, INC. | $29.97 | 2024 | Assure Wcd |
| Esperion Therapeutics, INC. | $17.29 | 2021 | |
| Amarin Pharma, INC. | $11.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Carollo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.